VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 1 filers reported holding VOR BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,244 | +412.3% | 15,681 | +646.7% | 0.00% | – |
| Q2 2023 | $6,489 | +3672.7% | 2,100 | -91.9% | 0.00% | -100.0% |
| Q4 2022 | $172 | -99.9% | 25,881 | -44.5% | 0.01% | +133.3% |
| Q3 2022 | $186,000 | +73.8% | 46,660 | +116.9% | 0.00% | +50.0% |
| Q2 2022 | $107,000 | -43.4% | 21,512 | -31.2% | 0.00% | 0.0% |
| Q1 2022 | $189,000 | -12.1% | 31,274 | +69.5% | 0.00% | -50.0% |
| Q4 2021 | $215,000 | +1854.5% | 18,450 | +2427.4% | 0.00% | – |
| Q3 2021 | $11,000 | -35.3% | 730 | -21.7% | 0.00% | – |
| Q2 2021 | $17,000 | -5.6% | 932 | +117.2% | 0.00% | – |
| Q1 2021 | $18,000 | – | 429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
| RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
| Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
| OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
| JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
| Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
| Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
| Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
| Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
| Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |